4.People with CKD who are treated with GLP-1 RAs or GLP-1 RA/GIP RA dual agonists need to only perform regular self-monitoring of blood glucose when they are also being treated with drugs that can cause hypoglycemia (sulfonylureas and insulins) (Grade 1A). This evidence concerns the gene GCG and chronic kidney disease.